💰 Context
Cannabis Bioscience International Holdings, Inc. educates people about cannabis and conducts clinical research. They make money by offering courses, consulting, and clinical trials. Recently, they faced challenges due to the COVID-19 pandemic, which affected their classroom-based education and consulting services.
📋 TL;DR
- 📉 Revenue Drop: Revenue decreased to $248,841 in 2024 from $316,825 in 2023.
- 💻 Online Shift: Moved focus to online education due to COVID-19.
- 🌍 Market Expansion: Planning to expand educational services in Latin America.
- 🔬 Clinical Trials: Conducting clinical trials for various medical conditions.
🚀 Trends
In 2024, the company saw a shift towards online education due to the COVID-19 pandemic. There was also an increasing demand for cannabis education and clinical trials, especially in the medical cannabis market. The company plans to expand its educational services in Latin America and continue focusing on online courses.
💰 Financial Performance
The company reported a revenue of $248,841 and a net loss of $651,345 for the fiscal year 2024. This was a decrease from the previous year's revenue of $316,825. The company's stock is not publicly traded, so there is no stock performance data available.
📈 Emerging Markets
The company is focusing on expanding its educational services in Latin America, including countries like Mexico, Peru, Ecuador, and the Dominican Republic. They plan to resume classroom and seminar activities in these regions post-pandemic.
🌿 Environmental Initiatives
The company has not detailed specific environmental initiatives in the report. However, they are committed to social responsibility and inclusiveness in their operations.
📱 Key Products
Key products include educational courses on medical cannabis, consulting services for cannabis businesses, and clinical trials for various medical conditions.
📰 Major Announcements
Major announcements include the shift to online education due to the COVID-19 pandemic and the plan to expand educational services in Latin America.
📊 Market Share
The company has a significant presence in the cannabis education and clinical research market, particularly in the United States and Latin America.
🌟 Social Impact
The company focuses on social responsibility, inclusiveness, and providing education on the medical properties of cannabis. They also work closely with law enforcement agencies to promote ethical practices in the cannabis industry.
🔮 Future Outlook
The company plans to expand its online education services and resume classroom activities in Latin America. They also aim to increase their clinical trials and consulting services. The company expects to become profitable in the year ending May 31, 2025.